| Clinical impact of aspirin resistance measured using the Ultegra Rapid Platelet Function Assay-ASA in patients undergoing percutaneous coronary intervention |
|
Ji Hye Yim, Seong-Wook Park, Seung-Whan Lee, Hyung Oh Choi, Pil Hyung Lee, Byung Joo Sun, Duk-Woo Park, Young-Hak Kim, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Ph, D., Seung-Jung Park |
|
|
| 관상동맥 스텐트 삽입술 후 Ultegra rapid platelet function Assay-ASA을 이용한 Aspirin 저항성의 임상적 의의 |
|
임지혜, 박성욱, 이승환, 최형오, 이필형, 선병주, 박덕우, 김영학, 이철환, 홍명기, 김재중, 박승정, D., Seung-Jung Park |
|
|
|
|
|
|
| Abstract |
|
Background/Aims: Aspirin resistance is reported to be associated with myocardial infarction, stroke, and myonecrosis after percutaneous coronary intervention. However, aspirin resistance and its clinical implications in patients undergoing drug-eluting stent (DES) implantation have not been evaluated sufficiently.
Methods: The study enrolled 419 consecutive patients who underwent DES implantation. All of the patients took aspirin 100 mg (228 patients, 54.4%) or 200 mg (191 patients, 45.6%). Aspirin resistance was measured using the Ultegra Rapid Platelet Function Assay-ASA (Accumetrics, San Diego, CA, USA). The results were expressed as aspirin reaction units (ARU). Aspirin resistance was defined as ARU ≥550. We followed all patients for 9 months.
Results: Aspirin resistance was found in 33 patients (33/419, 7.9%). The aspirin dose (118.18±39.2 vs. 147.93±50.0 mg, p=0.011) was lower in the aspirin-resistant (n=33) versus the aspirin-sensitive (n=386) group. There was no significant difference in the occurrence of myocardial necrosis (15.6% vs. 15.5%, p=0.988). On multivariate analysis, low-dose aspirin (odds ratio (OR) 4.714; 95% confidence interval (CI) 1.865-11.914; p=0.001), age (OR 1.048; 95% CI 1.005-0.092, p=0.029), platelet count (OR 1.007; 95% CI 1.001-1.014, p=0.011), and hypercholesterolemia (OR 2.937; 95% CI 1.310-6.583, p=0.009) were independent predictors of aspirin resistance. Over the 9 months, no stent thrombosis or death occurred; one acute myocardial infarction occurred in the aspirin-sensitive group.
Conclusions: Low-dose aspirin, old age, a higher platelet count, and hypercholesterolemia were associated with a high incidence of aspirin resistance in patients who underwent DES implantation. However, no significant differences in clinical outcome were found between the aspirin-resistant and -sensitive groups during a 9-month follow-up. |
| Key Words:
Aspirin resistance; Stent; Coronary artery disease |
|
PDF Links
Full text via DOI
Download Citation
